LEXAPRO

This brand name is authorized in United States. It is also authorized in Australia, Brazil, Ecuador, Hong Kong SAR China, Ireland, Japan, Mexico, Netherlands, New Zealand, Poland, Singapore.

Active ingredients

The drug LEXAPRO contains one active pharmaceutical ingredient (API):

1	Escitalopram UNII 5U85DBW7LO - ESCITALOPRAM OXALATE
	Escitalopram is a selective inhibitor of serotonin (5-HT) re-uptake with high affinity for the primary binding site. It also binds to an allosteric site on the serotonin transporter, with a 1000 fold lower affinity. The inhibition of 5-HT re-uptake is the only likely mechanism of action explaining the pharmacological and clinical effects of escitalopram.
	Read more about Escitalopram

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LEXAPRO Tablet / Oral solution	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AB10	Escitalopram	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10181W, 8700X, 8701Y, 9432K, 9433L
BR	Câmara de Regulação do Mercado de Medicamentos	524200302115317, 524200306110311, 524200307133313, 524200309111317, 524200311114311, 524217060003501, 524218030003603, 524218030003703, 524218030003803, 524220020004307
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.224-06-03, 25.225-06-03, 25.226-06-03, 25.227-06-03
HK	Department of Health Drug Office	50995, 50996, 50997, 50998
IE	Health Products Regulatory Authority	28574, 31216, 31317, 32348, 38752, 45870, 45891, 45922, 45923, 45924
JP	医薬品医療機器総合機構	1179054F1022, 1179054F2029
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	282M2002
NL	Z-Index G-Standaard, PRK	74969, 74977, 85081, 87998
NZ	Medicines and Medical Devices Safety Authority	11034, 11036
PL	Rejestru Produktów Leczniczych	100182660, 100290615, 100380436, 100396621, 100419670, 100461655
SG	Health Sciences Authority	12362P, 12363P, 12364P, 12365P
US	FDA, National Drug Code	0456-2005, 0456-2010, 0456-2020, 55289-768, 55289-828, 63629-2981